Divis Laboratories

Update in progress

DIVISLAB.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Divi’s Laboratories Limited manufactures and sells generic active pharmaceutical ingredients, intermediates, and nutraceuticals for markets worldwide. It provides custom synthesis and contract manufacturing services for APIs and intermediates, and supplies carotenoids such as beta carotene, astaxanthin, lycopene, canthaxanthin, lutein, and related vitamins for food, beverage, dietary supplements, pet food, and feed industries. Exports are a key part of its business. Based in Hyderabad, India, it was formerly Divi’s Research Center and took its current name in 1994, having been incorporated in 1990.

Company score

Sentiment: 0.29; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.10; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.03; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.20; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.14; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive